Trial Site Detail
Drug: |
Rogaratinib |
|||
|---|---|---|---|---|
Trial: |
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) |
|||
| Conditions: | Sarcoma | |||
Trial Status: |
Active, not recruiting |
|||
Washington University School of Medicine660 S. Euclid Ave |
Principal Investigator: |
Brian Van Tine, MD, PhD |
|---|---|
Contact: |
800-600-3606 info@siteman.wustl.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Washington University School of Medicine Website: |
http://www.siteman.wustl.edu/FindProtocol.aspx?id=625&mid=70 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.